Meanwhile, prophylactic application granulocyte‐colony stimulating factor (G‐CSF/CSF3) was observed to improve clinical outcome of elderly DLBCL patients receiving CHOP chemotherapy 22. The gene discussed is CSF3; the disease is diffuse large B-cell lymphoma.